Merck & Co Inc (NYSE:MRK)

88.39
Delayed Data
As of Oct 05
 0.00 / 0.00%
Today’s Change
71.50
Today|||52-Week Range
95.72
+15.33%
Year-to-Date
Is Exelixis' (EXEL) Growth Story Likely to Continue?
Oct 05 / Zacks.com - Paid Partner Content
What This News Means for Merck
Oct 01 / MotleyFool.com - Paid Partner Content
Iovance (IOVA) Focuses on Seeking Nod for Melanoma Therapy
Oct 05 / Zacks.com - Paid Partner Content
The Best Value Stock to Buy for the Long Term
Sep 29 / StockNews.com - Paid Partner Content
Merck (MRK) Gains But Lags Market: What You Should Know
Oct 03 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets Four New Approvals in Japan
Sep 28 / Zacks.com - Paid Partner Content
Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?
Oct 03 / Zacks.com - Paid Partner Content
Bear Market: 2 Safe Stocks to Buy Right Now
Sep 28 / MotleyFool.com - Paid Partner Content
2 Stocks to Add to Your Must-Buy List in Q4
Oct 03 / StockNews.com - Paid Partner Content
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
Sep 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close88.39
Today’s open88.60
Day’s range88.03 - 88.77
Volume6,065,661
Average volume (3 months)9,554,710
Market cap$218.2B
Data as of 4:00pm ET, 10/05/2022

Growth & Valuation

Earnings growth (last year)+84.65%
Earnings growth (this year)+22.76%
Earnings growth (next 5 years)+11.30%
Revenue growth (last year)+1.86%
P/E ratio13.5
Price/Sales3.98
Price/Book5.70

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.35-0.79%
ABBVAbbVie+1.23+0.87%
NVONovo Nordisk+0.60+0.57%
AZNAstraZeneca-0.34-0.60%
Data as of 4:00pm ET, 10/05/2022

Financials

Next reporting dateOctober 27, 2022
EPS forecast (this quarter)$1.75
Annual revenue (last year)$48.9B
Annual profit (last year)$13.0B
Net profit margin25.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts